✦ LIBER ✦

12 Pegylated Interferon and Ribavirin Therapy for 24 Weeks Versus Shorter Duration for Patients with Hepatitis C Virus Genotype 2 and 3 Infection and Rapid Virologic Response: A Meta-Analysis

✍ Scribed by Arif, Murtaza; Thapar, Manish; Matteson, Michelle L.; Choudhary, Abhishek; Szary, Nicholas M.; Puli, Srinivas R.; Bechtold, Matthew L.

Book ID: 122597366
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 108 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)63649-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon alfa and ribavirin

Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

✍ Olav Dalgard; Kristian Bjøro; Helmer Ring-Larsen; Einar Bjornsson; Mona Holberg- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

A recent nonrandomized pilot trial showed that hepatitis C virus (HCV) patients with genotype 2/3 and rapid virological response (RVR) had a 90% sustained virological response (SVR) rate after 14 weeks of treatment. We aimed to assess this concept in a randomized controlled trial. In the trial, 428

Rapid virological response tailors the d

Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin in Pakistan

✍ Gill, Uzma; Aziz, Hafsa; Gill, Muzaffar Lateef 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 460 KB

652 Meta-Analysis: Sustained Virologic R

652 Meta-Analysis: Sustained Virologic Response (SVR) in Asian Patients With Infection With Hepatitis C Virus Genotype 6 (HCV-6) Versus Genotype 1 (HCV-1) Treated With Pegylated Interferon and Ribavirin (PEG IFN+RBV) for 48 Weeks

✍ Nguyen, Nghia; McCormack, Shelley A.; Yee, Brittany E.; Vutien, Philip; Nguyen, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 585 KB

Eight-week regimen of antiviral combinat

Eight-week regimen of antiviral combination therapy with peginterferon and ribavirin for patients with chronic hepatitis C with hepatitis C virus genotype 2 and a rapid virological response

✍ Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Yasuhiro Sone; Makoto Tanikawa; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Rapid, early and sustained virological r

Rapid, early and sustained virological responses in a cohort of Irish patients treated with pegylated interferon and ribavirin for chronic hepatitis C virus infection

✍ S. Sarwar; E. J. Ryan; M. Iqbal; P. A. McCormick; C. O’Farrelly; J. Hegarty 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Su1074 Meta-Analysis: Sustained Virologi

Su1074 Meta-Analysis: Sustained Virologic Response (SVR) in Patients With Infection With Hepatitis C Virus Genotype 5 (HCV-5) Versus Genotype 1 (HCV-1) and HCV Genotype 2/3 (HCV -2/3) Treated With Interferon (IFN) or Pegylated Interferon and Ribavirin (PEG IFN+RBV)

✍ Devaki, Pardha; Jencks, David S.; Nangia, Sharad; Marupakula, Vidyasagargoud; Ng 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 609 KB